U.S. FDA Observations On Cadila’s Moraiya Plant Casts Shadow On Future Pipeline
Slimona brand Rimonabant diet pills, made by Cadila Healthcare Ltd., in Mumbai, India. (Photographer: Scott Eells/Bloomberg News)

U.S. FDA Observations On Cadila’s Moraiya Plant Casts Shadow On Future Pipeline

The U.S. drug regulator’s inspection at Cadila Healthcare Ltd.’s Moraiya facility—the largest contributor to the company’s U.S. business—has cast a shadow on the drugmaker’s future pipeline.The U.S...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.